Shattuck Labs, Inc.(STTK),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

STTK Shattuck Labs, Inc.

Pre-Mkt 04-29 05:54:27 EDT

0.8041

+0.0077

+0.97%

High0.8345	Low0.7531	Vol105.48K
Open0.8000	D1 Closing0.7964	Amplitude10.22%
Mkt Cap38.52M	Tradable Cap19.44M	Total Shares47.90M
T/O83.06K	T/O Rate0.44%	Tradable Shares24.18M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Invest in Global Markets with Tiger Brokers!

Open App

{"stockData":{"symbol":"STTK","market":"US","secType":"STK","nameCN":"Shattuck Labs, Inc.","latestPrice":0.8041,"timestamp":1745870400000,"preClose":0.7964,"halted":0,"volume":105475,"delay":0,"floatShares":24176030,"shares":47899240,"eps":-1.485668,"marketStatus":"Pre-Mkt","change":0.0077,"latestTime":"04-29 05:54:27 EDT","open":0.8,"high":0.8345,"low":0.7531,"amount":83056.963003,"amplitude":0.10221,"askPrice":1.02,"askSize":200,"bidPrice":0.6493,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-1.485668,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1745933400000},"marketStatusCode":1,"adr":0,"listingDate":1602216000000,"exchange":"NASDAQ","adjPreClose":0.8041,"postHourTrading":{"tag":"盘后","latestPrice":0.7637,"preClose":0.8041,"latestTime":"17:33 EDT","volume":1377,"amount":1099.7671,"timestamp":1745875983852},"volumeRatio":0.805456666696237,"impliedVol":0.8187,"impliedVolPercentile":0.3695},"requestUrl":"/m/hq/s/STTK/tweets","defaultTab":"tweets","newsList":[{"id":"2530407678","title":"Shattuck Labs Inc  expected to post a loss of 28 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2530407678","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530407678?lang=en_us&edition=full_marsco","pubTime":"2025-04-28 20:54","pubTimestamp":1745844864,"startTime":"0","endTime":"0","summary":"Shattuck Labs Inc  expected to post a loss of28cents a share - Earnings Preview Shattuck Labs Inc STTK.OQ STTK.O is expected to show a fall in quarterly revenue when it reports  results on April 30 (e","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250428:nL8N3R617X:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["STTK"],"gpt_icon":0},{"id":"2525215893","title":"3 Promising Penny Stocks With Market Caps Under $300M","url":"https://stock-news.laohu8.com/highlight/detail?id=2525215893","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525215893?lang=en_us&edition=full_marsco","pubTime":"2025-04-08 19:05","pubTimestamp":1744110301,"startTime":"0","endTime":"0","summary":"Amid ongoing market volatility and tariff uncertainties, the S&P 500 and Dow Jones Industrial Average have experienced significant declines, while the Nasdaq Composite showed a slight increase. For investors willing to explore beyond well-known companies, penny stocks—often associated with smaller or newer enterprises—can present unexpected opportunities. Despite their somewhat outdated label, these stocks remain relevant for those seeking potential growth driven by solid financial health.AirJoule Technologies, with a market cap of US$268.79 million, has transitioned to profitability, reporting a net income of US$215.7 million for 2024 after a prior loss. Despite having no significant revenue streams and being pre-revenue, the company benefits from strong short-term asset coverage over liabilities but faces challenges with long-term liabilities totaling US$113.7 million. The lack of debt is advantageous; however, its high volatility and inexperienced management team may pose risks. Rec","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/3-promising-penny-stocks-market-110501016.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4209","BK4023","STTK","BK4021","BK4509","TUSK","BK4179","TTI","BABB","SB","AIRJ","TUYA","BK4526","BK4505","AIRJW","BK4139","BK4563"],"gpt_icon":0},{"id":"2524441554","title":"Shattuck Labs Announces Participation in Upcoming 24th Annual Needham Virtual Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2524441554","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524441554?lang=en_us&edition=full_marsco","pubTime":"2025-04-03 05:00","pubTimestamp":1743627600,"startTime":"0","endTime":"0","summary":"AUSTIN, TX and DURHAM, NC, April 02, 2025  -- Shattuck Labs, Inc.  , a biotechnology company pioneering the development of novel therapeutics targeting tumor necrosis factor  superfamily receptors for the treatment of patients with inflammatory and immune-related diseases, today announced that company management will present at and participate in one-on-one meetings at the 24th Annual Needham Virtual Healthcare Conference, taking place April 7–10, 2025.Conference DetailsFormat: Presentation and one-on-one meetingsPresenter: Taylor Schreiber, M.D., Ph.D., Shattuck’s Chief Executive OfficerDate: April 9, 2025Time: 3:00 PM EDTWebcast link: HERE. About SL-325SL-325 is a potential first-in-class Death Receptor 3  blocking antibody designed to achieve a complete and durable blockade of the clinically validated DR3/TL1A pathway. Shattuck’s preclinical studies demonstrate high affinity binding and superior activity over TL1A antibodies, and offer a data-driven rationale for targeting the TNF r","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/shattuck-labs-announces-participation-upcoming-210000962.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IBD","STTK","BK4137","BK4139","HCSG"],"gpt_icon":0},{"id":"2522573704","title":"Shattuck Labs Full Year 2024 Earnings: Misses Expectations","url":"https://stock-news.laohu8.com/highlight/detail?id=2522573704","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522573704?lang=en_us&edition=full_marsco","pubTime":"2025-03-28 19:32","pubTimestamp":1743161569,"startTime":"0","endTime":"0","summary":"NasdaqGS:STTK Earnings and Revenue History March 28th 2025. All figures shown in the chart above are for the trailing 12 month  period. Revenue missed analyst estimates by 12%. Earnings per share  also missed analyst estimates by 2.9%.Looking ahead, revenue is expected to decline by 121% p.a. on average during the next 3 years, while revenues in the Biotechs industry in the US are expected to grow by 20%.The company's shares are down 5.0% from a week ago.We should say that we've discovered 5 warning signs for Shattuck Labs (2 shouldn't be ignored!) that you should be aware of before investing here.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/shattuck-labs-full-2024-earnings-113249237.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["STTK"],"gpt_icon":0},{"id":"2522419532","title":"Shattuck Labs Inc reports results for the quarter ended December 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2522419532","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522419532?lang=en_us&edition=full_marsco","pubTime":"2025-03-28 05:02","pubTimestamp":1743109326,"startTime":"0","endTime":"0","summary":"Shattuck Labs Inc reports results for the quarter ended December 31 - Earnings SummaryShattuck Labs Inc STTK.OQ reported a quarterly adjusted loss of 37 cents per share for the quarter ended December ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250327:nL5N3QA26D:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["STTK"],"gpt_icon":0},{"id":"2522615538","title":"Shattuck Labs’ SL-325: Promising Preclinical Results and Growth Potential Justify Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2522615538","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522615538?lang=en_us&edition=full_marsco","pubTime":"2025-03-28 02:05","pubTimestamp":1743098710,"startTime":"0","endTime":"0","summary":"TD Cowen analyst Marc Frahm has maintained their bullish stance on STTK stock, giving a Buy rating on March 17. Marc Frahm has given his Buy rating...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/shattuck-labs-sl-325-promising-preclinical-results-and-growth-potential-justify-buy-rating?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/shattuck-labs-sl-325-promising-preclinical-results-and-growth-potential-justify-buy-rating?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["STTK"],"gpt_icon":0},{"id":"2522586792","title":"Shattuck Labs: Hold Rating Due to Early Pipeline Stages and Lack of Near-Term Catalysts","url":"https://stock-news.laohu8.com/highlight/detail?id=2522586792","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522586792?lang=en_us&edition=full_marsco","pubTime":"2025-03-27 23:45","pubTimestamp":1743090328,"startTime":"0","endTime":"0","summary":"Needham analyst Gil Blum has maintained their neutral stance on STTK stock, giving a Hold rating today. Gil Blum has given his Hold rating due to a...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/shattuck-labs-hold-rating-due-to-early-pipeline-stages-and-lack-of-near-term-catalysts?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/shattuck-labs-hold-rating-due-to-early-pipeline-stages-and-lack-of-near-term-catalysts?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["STTK"],"gpt_icon":0},{"id":"2522375661","title":"BRIEF-Shattuck Labs Q4 Net Income USD -18.679 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2522375661","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522375661?lang=en_us&edition=full_marsco","pubTime":"2025-03-27 19:00","pubTimestamp":1743073247,"startTime":"0","endTime":"0","summary":"BRIEF-Shattuck Labs Q4 Net Income USD -18.679 Million\n\n\nMar 27 (Reuters) - Shattuck Labs Q4 basic EPS USD -0.37.\n\nQ4 income from operations USD -19.641 million","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250327:nPLX41161D:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["STTK","BK4139"],"gpt_icon":0},{"id":"2522375558","title":"Shattuck Labs Reports Fourth Quarter and Full-Year 2024 Financial Results and Recent Business Highlights","url":"https://stock-news.laohu8.com/highlight/detail?id=2522375558","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522375558?lang=en_us&edition=full_marsco","pubTime":"2025-03-27 19:00","pubTimestamp":1743073203,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250327:nTUA67JQLH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["STTK","BK4139"],"gpt_icon":0},{"id":"2522375968","title":"Shattuck Labs Inc - Cash Balance of $73 Million Expected to Fund Operations Into 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2522375968","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522375968?lang=en_us&edition=full_marsco","pubTime":"2025-03-27 19:00","pubTimestamp":1743073202,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250327:nPLX41161D:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["STTK","BK4139"],"gpt_icon":0},{"id":"2522375405","title":"Shattuck Labs Reports Fourth Quarter and Full-Year 2024 Financial Results and Recent Business Highlights","url":"https://stock-news.laohu8.com/highlight/detail?id=2522375405","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522375405?lang=en_us&edition=full_marsco","pubTime":"2025-03-27 19:00","pubTimestamp":1743073200,"startTime":"0","endTime":"0","summary":"– Presented preclinical non-human primate  data at the 20th Congress of European Crohn’s and Colitis Organization in Inflammatory Bowel Diseases 2025  for SL-325, a potentially first-in-class blocking antibody to DR3, the receptor for TL1A; data demonstrated favorable safety profile, full receptor occupancy, lack of DR3 agonism –。– SL-325 advances toward Phase 1; on track for IND filing in the third quarter of 2025 –。– Cash balance of approximately $73.0 million as of December 31, 2024, expected to fund operations into 2027 –。AUSTIN, TX and DURHAM, NC, March 27, 2025  -- Shattuck Labs, Inc.  , a biotechnology company pioneering the development of novel therapeutics targeting tumor necrosis factor  superfamily receptors for the treatment of patients with inflammatory and immune-mediated diseases, today reported financial results for the fourth quarter and full year ended December 31, 2024 and provided recent business highlights.Shattuck’s lead product candidate, SL-325, is a potentially","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/shattuck-labs-reports-fourth-quarter-110000089.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","IBD","STTK"],"gpt_icon":0},{"id":"2522838257","title":"Shattuck Labs Inc  expected to post a loss of 32 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2522838257","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522838257?lang=en_us&edition=full_marsco","pubTime":"2025-03-26 04:38","pubTimestamp":1742935089,"startTime":"0","endTime":"0","summary":"Shattuck Labs Inc  expected to post a loss of32cents a share - Earnings Preview Shattuck Labs Inc STTK.OQ STTK.O is expected to show a rise in quarterly revenue when it reports  results on March 27 (e","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250325:nL5N3Q821H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["STTK"],"gpt_icon":0},{"id":"2521254248","title":"Shattuck Labs Inc  expected to post a loss of 32 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2521254248","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521254248?lang=en_us&edition=full_marsco","pubTime":"2025-03-22 04:37","pubTimestamp":1742589476,"startTime":"0","endTime":"0","summary":"Shattuck Labs Inc  expected to post a loss of32cents a share - Earnings Preview Shattuck Labs Inc STTK.OQ STTK.O is expected to show a rise in quarterly revenue when it reports  results on March 24 (e","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250321:nL8N3Q4231:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["STTK"],"gpt_icon":0},{"id":"2520177523","title":"Shattuck Labs Initiated at Outperform by Leerink Partners","url":"https://stock-news.laohu8.com/highlight/detail?id=2520177523","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520177523?lang=en_us&edition=full_marsco","pubTime":"2025-03-17 20:31","pubTimestamp":1742214660,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/STTK/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 17, 2025 08:31 ET (12:31 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["STTK"],"gpt_icon":0},{"id":"2520544242","title":"Leerink Partners Initiates Shattuck Labs at Outperform With $4 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2520544242","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520544242?lang=en_us&edition=full_marsco","pubTime":"2025-03-17 19:35","pubTimestamp":1742211357,"startTime":"0","endTime":"0","summary":"Shattuck Labs (STTK) has an average rating of overweight and mean price target of $2.60, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["STTK"],"gpt_icon":0},{"id":"2520889517","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2520889517","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520889517?lang=en_us&edition=full_marsco","pubTime":"2025-03-17 18:00","pubTimestamp":1742205600,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.·Bitcoin Depot Inc.                               4Q       .02   8:05 AM. ·IHS Hldg Ltd.                                    4Q       .01   6:00 AM","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KOPN","DERM","BCAB","DMAC","AUTL","CAL","DRI","CMC","GLUE","BTM","AEVA","RWAY","SCPH","SIG","PHUN","SAIC","IMTX","RBOT","SGMO","OSS","LAR","RANI","OPTN","SPRY","NRXP","LXEO","CNTX","FIVE","BLTE","LQDA","ASO","LPRO","LVTX","MSIF","CELC","ABSI","INO","LEN.B","NOA","PL","KLC","ANRO","HYPR","STNE","FLUX","STTK","CBUS","OABI"],"gpt_icon":1},{"id":"2518774654","title":"Shattuck Labs Inc  expected to post a loss of 32 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2518774654","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518774654?lang=en_us&edition=full_marsco","pubTime":"2025-03-12 04:26","pubTimestamp":1741724773,"startTime":"0","endTime":"0","summary":"Shattuck Labs Inc  expected to post a loss of32cents a share - Earnings Preview Shattuck Labs Inc STTK.OQ STTK.O is expected to show a rise in quarterly revenue when it reports  results on March 13 (e","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250311:nL8N3PU2BB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["STTK"],"gpt_icon":0},{"id":"2518574959","title":"Favourable Signals For Shattuck Labs: Numerous Insiders Acquired Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2518574959","media":"Simply Wall St.","labels":["shareholding","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518574959?lang=en_us&edition=full_marsco","pubTime":"2025-03-11 20:34","pubTimestamp":1741696442,"startTime":"0","endTime":"0","summary":"Usually, when one insider buys stock, it might not be a monumental event. But when multiple insiders are buying like they did in the case of Shattuck Labs, Inc. , that sends out a positive message to the company's shareholders.While we would never suggest that investors should base their decisions solely on what the directors of a company have been doing, we do think it is perfectly logical to keep tabs on what insiders are doing.The Last 12 Months Of Insider Transactions At Shattuck Labs. There haven't been any insider transactions in the last three months -- that doesn't mean much. But insiders have shown more of an appetite for the stock, over the last year. The transactions are fine but it'd be more encouraging if Shattuck Labs insiders bought more shares in the company. In addition to knowing about insider transactions going on, it's beneficial to identify the risks facing Shattuck Labs. Be aware that Shattuck Labs is showing 4 warning signs in our investment analysis, and 2 of th","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/favourable-signals-shattuck-labs-numerous-123402185.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,merge","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["STTK","BK4139"],"gpt_icon":0},{"id":"2517989760","title":"Shattuck Labs Inc  expected to post a loss of 32 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2517989760","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517989760?lang=en_us&edition=full_marsco","pubTime":"2025-03-05 05:23","pubTimestamp":1741123390,"startTime":"0","endTime":"0","summary":"Shattuck Labs Inc  expected to post a loss of32cents a share - Earnings Preview Shattuck Labs Inc STTK.OQ STTK.O is expected to show a rise in quarterly revenue when it reports  results on March 6 (es","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250304:nL5N3PN2OF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["STTK"],"gpt_icon":0},{"id":"2516304949","title":"Shattuck Labs Inc  expected to post a loss of 32 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2516304949","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516304949?lang=en_us&edition=full_marsco","pubTime":"2025-03-01 05:33","pubTimestamp":1740778387,"startTime":"0","endTime":"0","summary":"Shattuck Labs Inc  expected to post a loss of32cents a share - Earnings Preview Shattuck Labs Inc STTK.OQ STTK.O is expected to show a rise in quarterly revenue when it reports  results on March 3 (es","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250228:nL5N3PJ2GP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["STTK"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.shattucklabs.com","stockEarnings":[{"period":"1week","weight":0.0242},{"period":"1month","weight":-0.2378},{"period":"3month","weight":-0.3186},{"period":"6month","weight":-0.3862},{"period":"1year","weight":-0.9241},{"period":"ytd","weight":-0.3355}],"compareEarnings":[{"period":"1week","weight":0.0719},{"period":"1month","weight":-0.0087},{"period":"3month","weight":-0.0888},{"period":"6month","weight":-0.0503},{"period":"1year","weight":0.0838},{"period":"ytd","weight":-0.0601}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company's lead product candidate is SL-172154, which is in Phase 1 clinical trial for the treatment of ovarian, fallopian tube, and peritoneal cancers. The company was incorporated in 2016 and is headquartered in Austin, Texas.","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":0.170853},{"month":2,"riseRate":0.4,"avgChangeRate":-0.049861},{"month":3,"riseRate":0.2,"avgChangeRate":-0.21466},{"month":4,"riseRate":0.6,"avgChangeRate":0.045811},{"month":5,"riseRate":0,"avgChangeRate":-0.22685},{"month":6,"riseRate":0.75,"avgChangeRate":0.034283},{"month":7,"riseRate":0.25,"avgChangeRate":-0.11323},{"month":8,"riseRate":0,"avgChangeRate":-0.1098},{"month":9,"riseRate":0,"avgChangeRate":-0.132219},{"month":10,"riseRate":0.25,"avgChangeRate":-0.161173},{"month":11,"riseRate":0.4,"avgChangeRate":-0.044457},{"month":12,"riseRate":1,"avgChangeRate":0.64078}],"exchange":"NASDAQ","name":"Shattuck Labs, Inc.","nameEN":"Shattuck Labs, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.33.2","shortVersion":"4.33.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Shattuck Labs, Inc.(STTK),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Shattuck Labs, Inc.(STTK) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Shattuck Labs, Inc.,STTK,Shattuck Labs, Inc.股票,Shattuck Labs, Inc.股票老虎,Shattuck Labs, Inc.股票老虎国际,Shattuck Labs, Inc.行情,Shattuck Labs, Inc.股票行情,Shattuck Labs, Inc.股价,Shattuck Labs, Inc.股市,Shattuck Labs, Inc.股票价格,Shattuck Labs, Inc.股票交易,Shattuck Labs, Inc.股票购买,Shattuck Labs, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Shattuck Labs, Inc.(STTK),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Shattuck Labs, Inc.(STTK) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction